-
公开(公告)号：EP2117590B1
公开(公告)日：2011-06-22
申请号：EP07857167.6
申请日：2007-12-31
申请人： Pevion Biotech Ltd.
IPC分类号： A61K39/145
CPC分类号： A61K39/145 , A61K39/0225 , A61K39/12 , A61K2039/5258 , A61K2039/53 , A61K2039/585 , C12N2760/12034 , C12N2760/16134 , C12N2760/16142
摘要： The present invention relates to the use of a lipid vesicle for the preparation of a medicament. The invention further relates to a method of treating and/or preventing a disease or disorder involving administering such a lipid vesicle to an animal in need thereof.
-
公开(公告)号：EP1833465B1
公开(公告)日：2010-03-17
申请号：EP05824123.3
申请日：2005-12-21
申请人： Pevion Biotech Ltd.
CPC分类号： A61K47/28 , A61K9/1272 , A61K9/19 , A61K31/704 , A61K39/015 , A61K39/12 , A61K39/145 , A61K2039/5258 , A61K2039/55555 , A61K2039/70 , C12N2760/16134 , C12N2760/16142 , C12N2760/16234
-
公开(公告)号：EP1991564A2
公开(公告)日：2008-11-19
申请号：EP07733909.1
申请日：2007-03-02
申请人： Mymetics Corporation , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , Pevion Biotech LTD.
CPC分类号： A61K9/1272 , A61K9/0019 , A61K9/0043 , A61K9/127 , A61K9/1271 , A61K39/12 , A61K39/21 , A61K2039/54 , A61K2039/545 , A61K2039/55555 , A61K2039/6018 , A61K2039/6075 , C07K14/005 , C12N2740/16122 , C12N2740/16134
摘要： The present invention relates to a virosome-like vesicle comprising at least a gp41-derived antigen or an analogue thereof, said gp41-derived antigen being located to the external surface of and/or encapsulated inside said vesicle and being in a convenient configuration for conferring said virosome-like vesicle with an ability to induce an immune response against a gp41 protein of a human immunodeficiency virus (HIV).
-
公开(公告)号：EP1676569A1
公开(公告)日：2006-07-05
申请号：EP04031022.9
申请日：2004-12-30
申请人： Pevion Biotech Ltd.
CPC分类号： A61K47/28 , A61K9/1272 , A61K9/19 , A61K31/704 , A61K39/015 , A61K39/12 , A61K39/145 , A61K2039/5258 , A61K2039/55555 , A61K2039/70 , C12N2760/16134 , C12N2760/16142 , C12N2760/16234
摘要： The present invention relates to compositions and methods for the effective lyophilization and reconstitution of virosomes.
摘要翻译： 本发明涉及用于有效冻干和重构病毒颗粒的组合物和方法。
-
公开(公告)号：EP1991564B1
公开(公告)日：2013-09-11
申请号：EP07733909.1
申请日：2007-03-02
申请人： Mymetics Corporation , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , Pevion Biotech Ltd.
CPC分类号： A61K9/1272 , A61K9/0019 , A61K9/0043 , A61K9/127 , A61K9/1271 , A61K39/12 , A61K39/21 , A61K2039/54 , A61K2039/545 , A61K2039/55555 , A61K2039/6018 , A61K2039/6075 , C07K14/005 , C12N2740/16122 , C12N2740/16134
-
公开(公告)号：EP2102345A1
公开(公告)日：2009-09-23
申请号：EP07856822.7
申请日：2007-12-18
发明人： GRUNWALD, Thomas , ÜBERLA, Klaus
IPC分类号： C12N15/45 , C07K14/135 , C12N15/85 , C12N15/861 , A61K39/155
CPC分类号： A61K39/155 , A61K39/12 , A61K2039/53 , A61K2039/543 , C07K14/005 , C12N2710/10343 , C12N2760/18522 , C12N2760/18534
摘要： The present invention relates to a nucleic acid molecule, which codes for the F-protein of the respiratory syncytial virus (RSV) or a fragment thereof, for the expression in a human cell environment of codon optimized variants of said nucleic acid molecule, vectors and compositions comprising said nucleic acid molecules and the use thereof as vaccines and polypeptides coded by the nucleic acid molecules and method for the production thereof.
-
7.发明公开
公开(公告)号：EP1680446A2
公开(公告)日：2006-07-19
申请号：EP04818758.7
申请日：2004-11-05
申请人： Pevion Biotech Ltd.
发明人： ZURBRIGGEN, Rinaldo
IPC分类号： C07K14/435 , A61K39/39 , A61K35/64
CPC分类号： C07K14/43572 , A61K39/39 , A61K2039/55516
摘要： The present invention provides novel adjuvant systems for the potentiation of immune responses against antigenic targets.
-
公开(公告)号：EP2201109B1
公开(公告)日：2012-10-03
申请号：EP08802426.0
申请日：2008-09-19
CPC分类号： A61K39/0002 , A61K38/00 , C12N9/6478 , C12Q1/68 , G01N33/573 , Y02A50/471 , Y02A50/473
摘要： The present invention relates to a truncated form of the secretory aspartyl proteinase 2 (Sap2), as well as to nucleic acid molecules encoding same. This truncated Sap2 polypeptide (tSap2) is surprisingly stable and devoid of enzymatic activity but retains full immunogenicity upon intravaginal administration and confers full protection against intravaginal challenge by the Candida fungus. The present invention further relates to compositions comprising tSap2 and to the use of tSap2 in the preparation of such compositions.
摘要翻译： 本发明涉及分泌型天冬氨酰蛋白酶2（Sap2）的截短形式，以及编码其的核酸分子。 这种截短的Sap2多肽（tSap2）令人吃惊地稳定，没有酶活性，但在阴道内给药时保留完全的免疫原性，并赋予假丝酵母属真菌侵袭阴道内攻击的完全保护作用。 本发明还涉及包含tSap2的组合物和tSap2在制备这些组合物中的用途。
-
公开(公告)号：EP2102345B1
公开(公告)日：2011-03-16
申请号：EP07856822.7
申请日：2007-12-18
发明人： GRUNWALD, Thomas , ÜBERLA, Klaus
IPC分类号： C12N15/45 , C07K14/135 , C12N15/85 , C12N15/861 , A61K39/155
CPC分类号： A61K39/155 , A61K39/12 , A61K2039/53 , A61K2039/543 , C07K14/005 , C12N2710/10343 , C12N2760/18522 , C12N2760/18534
摘要： The present invention relates to a nucleic acid molecule, which codes for the F-protein of the respiratory syncytial virus (RSV) or a fragment thereof, for the expression in a human cell environment of codon optimized variants of said nucleic acid molecule, vectors and compositions comprising said nucleic acid molecules and the use thereof as vaccines and polypeptides coded by the nucleic acid molecules and method for the production thereof.
-
10.发明授权METHODS FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES 有权合成方法阻碍构象肽PEPTIDOMETIKA及其作为合成疫苗
公开(公告)号：EP1629002B1
公开(公告)日：2009-01-07
申请号：EP04739532.2
申请日：2004-06-02
IPC分类号： C07K7/56 , C07K1/04 , C07K16/20 , A61K38/12 , A61K39/015
CPC分类号： G01N33/56911 , A61K38/00 , A61K39/00 , A61K39/015 , C07K7/56 , C07K16/205 , Y02A50/412 , Y02A50/58
摘要： The present invention relates to methods for synthesizing conformationally constrained peptides and cyclic peptidomimetics obtainable by these methods which are conformationally constrained due an internal cross-link. This cross-link is formed between the side chain of an amino acid residue or analog and a (2S,4S)-4-functionalized proline residue. The invention further relates to the use of (2S,4S)-4-functionalized proline residues as building units in the synthesis of such peptidomimetics and to the use thereof as antigens, alone or in combination with suitable immunopotentiating delivery systems, for example immunopotentiating reconstituted influenza virosomes to elicit an immune response in a mammal. Moreover, the invention also relates to pharmaceutical compositions containing the same.
-
-
-
-
-
-
-
-
-
搜索结果
24 条记录 (耗时 0.015 秒)
